Newly diagnosed diabetes in patients with mild to moderate COVID-19
- 3 March 2021
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (2), 569-571
- https://doi.org/10.1016/j.dsx.2021.02.034
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infectionThe American Journal of Emergency Medicine, 2020
- Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetesDiabetes & Metabolism, 2020
- Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case seriesCurrent Therapeutic Research, 2020
- Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Newly diagnosed diabetes in COVID-19 patientsPrimary Care Diabetes, 2020
- Newly diagnosed diabetes mellitus, DKA, and COVID‐19: Causality or coincidence? A report of three casesJournal of Medical Virology, 2020
- COVID-19 in people with diabetes: understanding the reasons for worse outcomesThe Lancet Diabetes & Endocrinology, 2020
- Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitusDiabetes Research and Clinical Practice, 2020
- Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerationsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2020Diabetes Care, 2019